Zacks.com on MSN16h
NSPR Stock May Gain as First Patient Enrolls in CGUARDIANS II Study
InspireMD Inc. NSPR recently announced the first patient enrolment in the company’s CGUARDIANS II clinical trial. The trial ...
Endovascular Today2d
InspireMD Commences CGUARDIANS II Pivotal Study of CGuard Prime Carotid Stent System in TCAR
InspireMD, Inc. announced that the first patient has been enrolled in the company’s CGUARDIANS II clinical trial evaluati ...
Too Old to Operate1d
Surgical and Endovascular Approaches to Extracranial Carotid Artery Aneurysms
The following is a summary of “Management of large or giant Extracranial carotid artery aneurysms: a single-center experience ...
Girl, 15, fatally stabbed 'standing up for friend'
A 15-year-old girl was fatally stabbed while standing up for a friend who had wanted to get back her teddy bear from her ...
InspireMD initiated with a Buy at Lake Street
Lake Street analyst Frank Takkinen initiated coverage of InspireMD (NSPR) with a Buy rating and $5 price target InspireMD’s CGuard carotid ...
The best gift is the gift of life with early detection
Frankie Maldonado, Director of Operations with Life Guard Imaging joins Gayle Guyardo, the host of the global health and wellness show, Bloom, to discuss the best gift – the ...